Johnson Pharmacare Limited

As of June 30, 2026, Johnson Pharmacare Limited carries a market capitalization of 275.00M, placing it among publicly traded companies globally. Its enterprise value stands at 275.00M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Johnson Pharmacare Limited has 550.00M shares outstanding.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately - - in revenue per employee across its workforce of 4.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Johnson Pharmacare Limited's stock has declined approximately 39.06% over the past 52 weeks. The 50-day moving average sits at 0.45, while the 200-day moving average is 0.51.

Over the twelve months ended June 30, 2026, Johnson Pharmacare Limited generated - - in revenue and converted that into -567.81M in net income, yielding earnings per share of -1.03. EBITDA reached -570.41M, while operating income came in at -427.71M.

Johnson Pharmacare Limited's most recent stock split took place on April 7, 2022 with a 10:11 split ratio.